Audit Team Transition and Regulatory Status Update – TruScreen Group Limited

TruScreen Group Limited, which trades on both the New Zealand and Australian exchanges, disclosed on 18 November that it has completed a change in its audit engagement. The former audit partner, Mr Vinay Sheoran of Hall Chadwick (NSW), has retired, and the firm has appointed Mr Drew Townsend—also of Hall Chadwick (NSW)—to assume the role of registered audit provider. This appointment satisfies the requirements of the Financial Markets Conduct reporting rules and has been duly endorsed by the board for filing with the relevant exchanges.

The announcement was accompanied by a concise reminder of TruScreen’s core business activities. The company is a developer of an artificial‑intelligence‑enabled cervical‑screening device that acquires real‑time optical and electrical signals to identify abnormal cervical cells. The device has been approved for use in a broad spectrum of international regulatory jurisdictions, including the European Union, the United Kingdom, Australia, China, Saudi Arabia, Russia, and Mexico. Additional ministry‑of‑health approvals have been obtained in several other countries.

TruScreen markets its device through distributors in more than twenty‑nine countries and has recently expanded its manufacturing capacity by establishing a production facility in China. No further financial or operational information was provided in the release; the primary focus remained on the audit transition and the continued adherence to regulatory requirements across the company’s medical‑device portfolio.